DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,363,675 | -20.4% | 4,951,303 | 0.0% | 23.76% | -13.0% |
| Q2 2023 | $55,702,159 | -2.3% | 4,951,303 | 0.0% | 27.32% | +14.9% |
| Q1 2023 | $57,039,011 | -0.6% | 4,951,303 | 0.0% | 23.77% | -1.0% |
| Q4 2022 | $57,385,602 | -8.7% | 4,951,303 | 0.0% | 24.01% | +0.3% |
| Q3 2022 | $62,882,000 | +84.9% | 4,951,303 | 0.0% | 23.95% | +66.9% |
| Q2 2022 | $34,015,000 | -28.7% | 4,951,303 | 0.0% | 14.35% | -12.0% |
| Q1 2022 | $47,731,000 | -18.9% | 4,951,303 | 0.0% | 16.31% | +28.2% |
| Q4 2021 | $58,871,000 | -26.8% | 4,951,303 | 0.0% | 12.72% | -31.7% |
| Q3 2021 | $80,409,000 | -22.8% | 4,951,303 | 0.0% | 18.64% | -3.8% |
| Q2 2021 | $104,175,000 | +35.5% | 4,951,303 | 0.0% | 19.37% | +30.4% |
| Q1 2021 | $76,894,000 | -26.0% | 4,951,303 | 0.0% | 14.86% | +1.0% |
| Q4 2020 | $103,977,000 | +4.0% | 4,951,303 | 0.0% | 14.71% | -21.1% |
| Q3 2020 | $99,967,000 | – | 4,951,303 | – | 18.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |